Movatterモバイル変換


[0]ホーム

URL:


CN120025281A - An intermediate of N,N-diisobutyl-1H-indazole-4-amine and preparation method thereof - Google Patents

An intermediate of N,N-diisobutyl-1H-indazole-4-amine and preparation method thereof
Download PDF

Info

Publication number
CN120025281A
CN120025281ACN202510502259.4ACN202510502259ACN120025281ACN 120025281 ACN120025281 ACN 120025281ACN 202510502259 ACN202510502259 ACN 202510502259ACN 120025281 ACN120025281 ACN 120025281A
Authority
CN
China
Prior art keywords
compound
formula
preparation
alkyl
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202510502259.4A
Other languages
Chinese (zh)
Inventor
黄林
张晗月
李原强
侯美凤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiuzhou Pharmaceutical Hangzhou Co ltd
Original Assignee
Jiuzhou Pharmaceutical Hangzhou Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiuzhou Pharmaceutical Hangzhou Co ltdfiledCriticalJiuzhou Pharmaceutical Hangzhou Co ltd
Priority to CN202510502259.4ApriorityCriticalpatent/CN120025281A/en
Publication of CN120025281ApublicationCriticalpatent/CN120025281A/en
Pendinglegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

The invention relates to the field of organic synthesis, in particular to an intermediate for synthesizing N, N-diisobutyl-1H-indazole-4-amine and a preparation method thereof, wherein 4-nitro-1-H-indazole is taken as a reaction raw material, and a benzyl protecting group is introduced, and then the intermediate of the compound N, N-diisobutyl-1H-indazole-4-amine is obtained through reduction reaction, continuous substitution and debenzylation reaction, and a novel preparation method thereof. The method improves the total reaction yield to 23%, and has the advantages of simple process operation, mild reaction conditions, few byproducts, high substrate universality and higher economic benefit.

Description

Intermediate of N, N-diisobutyl-1H-indazole-4-amine and preparation method thereof
Technical Field
The invention relates to the field of organic chemistry, in particular to an intermediate of N, N-diisobutyl-1H-indazole-4-amine and a preparation method thereof.
Background
The functionalization of the nitrogen-containing heterocyclic compound has wide application in the fields of dye preparation, pharmaceutical chemistry, material science and the like, and is an important research field of organic chemistry. The indazole is a heterocyclic compound containing adjacent nitrogen atoms, widely exists in dye molecules, and has a unique chemical structure and good dyeing property. And the dye can be used as precursors of a plurality of leading edge dyes such as squaraine salt and the like, thereby having bright development prospect. The squarylium dye has excellent blocking property for near infrared light and high transmittance for visible light, and thus is widely used as a leading edge dye in dye-sensitized solar cells, optical filters and imaging devices. Over the years, a variety of commercial squaraine dyes have been synthesized and the market still requires improved and newer better structures to further increase the transmittance to visible light and improve optical performance. For example, A1-10 reported in patent (CN 108603038A) is an excellent squarylium-based pigment, which has good compatibility in transparent resins, and even a thin absorption layer has good spectral characteristics, thereby further reducing the volume of the optical filter. The preparation method comprises the steps of taking 2, 6-difluorobenzaldehyde as a raw material, carrying out nucleophilic substitution reaction with diisobutylamine, cyclizing with ammonia water, purifying by a chromatographic column, wherein the yield of N, N-diisobutyl-1H-indazole-4-amine is only 13%, and finally condensing with squaric acid to generate A1-10, wherein the total yield is 0.94%.
N, N-diisobutyl-1H-indazol-4-amine is used as a key precursor of A1-10, the preparation process is only two steps, but the reaction time is too long, and by-products are generated, so that the single-step yield is very low (13%), and the product purification is difficult. Therefore, a new process which is simple and convenient to operate, easy to purify the product and high in total yield is necessary to be developed.
Disclosure of Invention
In order to solve the defects in the prior art, the technical scheme provided by the invention is as follows:
First, the present invention provides a compound of formula (I), having the structural formula:
,
Wherein:
a is a 4-7 membered unsaturated heterocyclic ring containing 1-2 hetero atoms N, O;
n is an integer of 1 to 6;
R1 is a substituent group comprising H or alkyl, alkoxy, wherein the alkyl can be methyl, ethyl, propyl, isopropyl;
Q is each independently HR3 or R2,R3 and R2 may be one or more-CH2-C1-6 alkyl, -CH2-C1-6 alkoxy, halo-CH2-C1-6 alkyl.
When Q is defined as HR3 in the above compounds of formula (I), the compound of formula (l) has the structure of formula (Ia):
,
When Q is defined as R2 in the above compound of formula (I) and is one or more-CH2-C1-6 alkyl groups, the compound of formula (I) has the structure of formula (Ib):
,
wherein A is 5-membered unsaturated heterocycle containing 1-2 hetero atoms N, O;
n, p is an integer of 1 to 2;
r1 is H or alkyl.
In a preferred embodiment of the present invention, A is preferably a 5-to 6-membered unsaturated heterocyclic ring containing 1 to 2 hetero atoms N, O, more preferably a 5-membered unsaturated heterocyclic ring containing 1 to 2 hetero atoms N, O, still more preferably A is the following group:
,,,, . Wherein, the two left side connection bonds of the preferable group A are connected with benzene rings adjacent to A in the structure of the formula (I), and actually form the structure of A and benzene rings. The bond on the right side or lower side of the A group is connected with the structural formula (I)A group.
N is preferably an integer of 1 to 3, more preferably an integer of 1 to 2.
R1 is preferably H or alkyl, preferably H.
Q is preferably HR3 or R2,R3 and R2 is preferably 1 or more-CH2-C1-6 alkyl, -CH2-C1-6 alkoxy, halo-CH2-C1-6 alkyl, more preferably 1 to 2 CH2-C1-3 alkyl, -CH2-C1-3 alkoxy, still more preferably 1 to 2-CH2-C1-3 alkyl, still more preferably 1 to 2-CH2-C1-3 alkyl.
The present invention provides the following preferred compounds of formula (I), in particular:
,,
Further, the compound of the general formula (I) provided by the invention can be prepared by a synthetic method shown in the following, wherein the method comprises the steps of preparing the compound of the formula (II) through a reduction reaction of the compound of the formula (III), and preparing the compound of the general formula (I) through a continuous substitution reaction of the compound of the formula (II), wherein the reaction equation is as follows:
wherein, A, n, R1, Q are defined as above.
The preparation method further comprises the following reaction equation,
,
Wherein A is a 5-membered unsaturated heterocyclic ring containing 2 heteroatoms N;
n is 1, R1 is H, R3 and R2 are 1 or more-CH2-C1-6 alkyl groups.
Or a reaction equation as follows,
Wherein A is a 5-membered unsaturated heterocyclic ring containing 2 heteroatoms N, N, p is 1, and R1 is H.
A preferred embodiment of the present invention is:
,
or as shown in the following,
The invention provides a preparation method for synthesizing N, N-diisobutyl-1H-indazole-4-amine (a 5) and an intermediate thereof, and more preferably an embodiment has the following general reaction equation:
The specific implementation mode is that the method I comprises the steps of preparing the compound (A5-1) by continuous substitution reaction of the compound (A3-1) in a solvent under alkaline conditions, the method II comprises the steps of preparing the compound (A3-2) by reduction reaction of the compound (A2-2) in an acidic environment in the presence of a reducing agent, preparing the compound (A4-2) by halogenated hydrocarbon substitution of the compound (A3-2), and preparing the compound (A5-2) by halogenated hydrocarbon substitution of the compound (A4-2).
In some embodiments, the compound (A3-1) or the compound (A2-2) referred to in the above methods one and two can be prepared from the compound A. The compound N, N-diisobutyl-1H-indazol-4-amine can be prepared from intermediate (A5-1) or intermediate (A5-2).
In the method of the present invention, the first method is a nucleophilic substitution reaction. The base may be one of sodium carbonate, sodium bicarbonate, potassium carbonate, potassium phosphate (including monobasic potassium phosphate, dibasic potassium phosphate and tribasic potassium phosphate), sodium phosphate (including monobasic sodium phosphate, dibasic sodium phosphate and tribasic sodium phosphate), preferably potassium carbonate. The base may be 1.0 to 1.3 eq, preferably 1.0 to 1.1 eq, preferably 1.05 eq. The reaction may be carried out in the presence of one or more solvents selected from the group consisting of N, N-dimethylformamide, tetrahydrofuran, dichloromethane, N-methylpyrrolidone, hexamethylphosphoramide, dimethyl ether, dimethyl sulfoxide. Preferably, the solvent may be N, N-dimethylformamide, tetrahydrofuran or dichloromethane. More preferably, the solvent may be N, N-dimethylformamide.
In the method of the present invention, the reaction step (i) in the second method is a reduction reaction. The reducing agent can be iron powder, zinc powder, preferably iron powder. The acidic condition may be ammonium chloride, hydrochloric acid, sulfuric acid, preferably ammonium chloride. The iron powder is used in an amount of 1.0-2.5 eq, preferably 1.7 eq eq. The solvent is selected from tetrahydrofuran, hexamethylphosphoramide, C1-C5 alcohol, dimethyl ether, diethyl ether, diisopropyl ether, ethyl acetate, dimethoxyethane and toluene. Preferably, the solvent may be water, tetrahydrofuran or a C1-C5 alcohol (such as methanol, ethanol, propanol, isopropanol, butanol, etc.). More preferably, the solvent may be a mixed solvent of ethanol and water in a ratio of 5:1, 4:1, 1:2, preferably 4:1.
In the process of the present invention, the reaction step (ii) in the second process is a substitution reaction. The base may be one of sodium carbonate, sodium bicarbonate, potassium carbonate, potassium phosphate (including monobasic potassium phosphate, dibasic potassium phosphate and tribasic potassium phosphate), sodium phosphate (including monobasic sodium phosphate, dibasic sodium phosphate and tribasic sodium phosphate), preferably potassium carbonate. The base may be 1.0 to 1.3 eq, preferably 1.0 to 1.1 eq, preferably 1.05 eq. The reaction solvent is selected from N, N-dimethylformamide, tetrahydrofuran, dichloromethane, N-methylpyrrolidone, hexamethylphosphoramide, dimethyl ether and dimethyl sulfoxide. Preferably, the solvent may be N, N-dimethylformamide, tetrahydrofuran or dichloromethane. More preferably, the solvent may be N, N-dimethylformamide.
In the method of the present invention, the reaction step (iii) in the method II is a substitution reaction. The base may be any one of lithium bis (trimethylsilyl) amide, sodium bis (trimethylsilyl) amide, potassium bis (trimethylsilyl) amide, sodium hydride, preferably lithium bis (trimethylsilyl) amide. The base may be 1.0 to 1.3 eq, preferably 1.0 to 1.1 eq, preferably 1.05 eq. The solvent for the reaction is selected from tetrahydrofuran, toluene, dimethyl ether, diethyl ether and diisopropyl ether. Preferably, the solvent may be tetrahydrofuran or dimethyl ether. More preferably, the solvent is tetrahydrofuran.
In the method of the present invention, the compound (A3-1) or the compound (A2-2) is produced from the compound (A) in a solvent under basic conditions. The base may be one of sodium carbonate, sodium bicarbonate, potassium carbonate, potassium phosphate (including monobasic potassium phosphate, dibasic potassium phosphate and tribasic potassium phosphate), sodium phosphate (including monobasic sodium phosphate, dibasic sodium phosphate and tribasic sodium phosphate), preferably potassium carbonate. The reaction solvent is selected from N, N-dimethylformamide, tetrahydrofuran, dichloromethane, N-methylpyrrolidone, hexamethylphosphoramide, dimethyl ether and dimethyl sulfoxide. Preferably, the solvent may be N, N-dimethylformamide, tetrahydrofuran or dichloromethane. More preferably, the solvent may be N, N-dimethylformamide.
In the process of the present invention, the compound N, N-diisobutyl-1H-indazol-4-amine is prepared from intermediate (A5-1) or intermediate (A5-2) in a solvent under basic conditions. The alkalinity may be one of potassium tert-butoxide, sodium hydride, preferably potassium tert-butoxide. The reaction may be carried out in the presence of one or more solvents selected from the group consisting of N, N-dimethylformamide, tetrahydrofuran, N-methylpyrrolidone, hexamethylphosphoramide, dimethyl ether, dimethyl sulfoxide. Preferably, the solvent may be N, N-dimethylformamide, tetrahydrofuran, dimethyl sulfoxide. More preferably, the solvent may be tetrahydrofuran, dimethyl sulfoxide.
Compared with the prior art, the invention has the beneficial effects that the intermediate of the compound N, N-diisobutyl-1H-indazole-4-amine and the novel preparation method are prepared by taking the 4-nitro-1-H-indazole as a reaction raw material and introducing a benzyl protecting group, then carrying out reduction reaction, continuous substitution and debenzylation reaction, the method improves the total reaction yield to 23 percent, the process is simple to operate, the reaction condition is mild, the byproducts are few, the universality of the substrate is high, and the economic benefit is higher,
Detailed Description
The following detailed description of the preferred embodiments of the invention is provided to enable those skilled in the art to more readily understand the advantages and features of the invention and to make a clear and concise definition of the scope of the invention.
Example 1
Adding a compound A (9.95 g,61 mmol) and potassium carbonate (16.86 g,122 mmol) into a 250mL three-neck round-bottom flask under the condition of 18 ℃ and nitrogen, rapidly adding ultra-dry N, N-dimethylformamide (120 mL), dissolving and stirring, dropwise adding bromobenzyl (11.48 g,67 mmol) after 10 minutes, reacting for 17 hours, detecting a sampling point plate, indicating that the raw materials disappear, generating target products, having more impurity points, adding 300 mL water for quenching and stirring, extracting 3 times (50 mL of x 3) with a large amount of water and ethyl acetate, collecting an organic phase, washing 3 times with a large amount of saline solution, collecting the organic phase, drying with anhydrous sodium sulfate, spinning the filtrate at 43 ℃ to obtain black solid, adding ethyl acetate for dissolving, adding a proper amount of silica gel powder, spinning to be powdery, dry-loading, collecting two products by the points respectively with N-hexane for leaching solution, and obtaining a golden yellow solid compound A2-1(7.43 g,48.1%).1H NMR (400 MHz, Chloroform-d) δ 8.67 (s, 1H), 8.13 (d, J = 7.6 Hz, 1H), 7.69 (d, J = 8.4 Hz, 1H), 7.44 (t, J = 8.0 Hz, 1H), 7.34 – 7.29 (m, 3H), 7.21 – 7.19 (m, 2H), 5.69 (s, 2H). to obtain an orange solid compound A2-2(6.95 g,45.0%).1H NMR (400 MHz, Chloroform-d) δ 8.58 (s, 1H), 8.19 (d, J = 7.6 Hz, 1H), 8.12 (d, J = 8.4 Hz, 1H), 7.43-7.35 (m, 6H), 5.68 (s, 2H).
Example 2
Weighing compound A2-1 (7.43 g,29.3 mmol), iron powder (16.4 g,293 mmol) and ammonium chloride (785 mg,14.7 mmol) in a 500 mL three-neck flask at 24deg.C (room temperature), adding 196 mL ethanol and 49 mL water under nitrogen, stirring, transferring to a 98 deg.C oil bath for heating reflux for 1 hr, sampling, quenching with potassium carbonate solution, extracting with ethyl acetate to obtain the target product, removing the oil bath for cooling, filtering with funnel and silica gel, washing with ethanol, collecting filtrate, removing ethanol by steaming under reduced pressure at 50deg.C, dissolving with ethyl acetate and adding potassium carbonate solution to adjust pH=8, extracting, washing with ethyl acetate for 3 times (75 mL×3), collecting organic phase, drying with saturated salt for 1 time, collecting organic phase, drying with anhydrous sodium sulfate under reduced pressure, steaming under 43 deg.C to obtain coarse orange solid compound A3-1(6.41 g,98%).1H NMR (400 MHz, Chloroform-d) δ 7.98 (d, J = 1.0 Hz, 1H), 7.30 – 7.26 (m, 3H), 7.20 – 7.18 (m, 2H), 7.15 – 7.11 (m, 1H), 6.75 (d, J = 8.3 Hz, 1H), 6.33 (d, J = 7.4 Hz, 1H), 5.54 (s, 2H), 4.15-4.10 (m, 2H).
Weighing A2-2 (6.95 g,27.5 mmol), iron powder (15.18 g,275 mmol) and ammonium chloride (738 mg,13.8 mmol) in a 500 mL three-neck flask at 24 ℃ under nitrogen, adding 164 mL ethanol and 41 mL water, stirring, transferring to a 78 ℃ oil bath, heating and refluxing for 2 hours, sampling, quenching with potassium carbonate solution, extracting with ethyl acetate to obtain a point plate, finding the disappearance of the raw material, generating a target product with more impurities, removing the oil bath for cooling, filtering with a funnel and silica gel, washing with ethanol, collecting filtrate, dissolving with ethyl acetate and adding potassium carbonate solution for pH=8 after 50 ℃ reduced pressure rotary evaporation to remove ethanol, extracting, washing with ethyl acetate for 3 times (75 mL×3), collecting an organic phase, washing with saturated salt for 1 time, collecting organic phase, drying with anhydrous sodium sulfate under reduced pressure, evaporating the organic phase under 43 ℃ to obtain a grey green solid compound A3-2(5.65 g,92%).1H NMR (400 MHz, Chloroform-d) δ 7.82 (s, 1H), 7.40-7.35 (m, 3H), 7.31-7.29 (m, 2H), 7.21 – 7.19 (m, 1H), 7.12 (dd, J = 8.7, 7.0 Hz, 1H), 6.29 – 6.27 (m, 1H), 5.59 (s, 2H), 3.61 (s, 2H).
Example 3
,
Weighing compound A3-1 (6.41 g,28.7 mmol) and potassium carbonate (11.9 g,86.0 mmol) in a 500 mL three-port bottle at a temperature of 22 ℃ and under nitrogen, adding 65 mL of N, N-dimethylformamide, dissolving and stirring for 10 minutes, slowly adding iodoisobutane (10.5 g,57.4 mmol), transferring to a 130 ℃ oil bath pot, heating and reacting for 12 hours, cooling to the room temperature, sampling and quenching with water, extracting with ethyl acetate, wherein an extraction point plate shows that the raw materials are completely reacted, generating a target product, transferring out of the oil bath pot, cooling to the room temperature, filtering and removing potassium carbonate with a sand core funnel, washing with ethyl acetate, collecting filtrate, extracting with a large amount of water and ethyl acetate for 3 times (50 mL of 3), collecting an organic phase, washing with saturated saline for three times, collecting the organic phase, adding anhydrous sodium sulfate for drying, evaporating the organic phase under reduced pressure at 43 ℃ to obtain a crude product, and separating with a column (ethyl acetate: n-hexane=1:30-1:10), obtaining compound A534 to obtain a light yellow solid of 531-5 m-white compound A (385 mg,4%).1H NMR (400 MHz, Chloroform-d) δ 8.10 (d, J = 1.0 Hz, 1H), 7.40 – 7.31 (m, 2H), 7.30 – 7.25 (m, 3H), 7.20 (t, J = 8.0 Hz, 1H), 6.72 (d, J = 8.2 Hz, 1H), 6.30 (d, J = 7.8 Hz, 1H), 5.54 (s, 2H), 3.38 (d, J = 7.2 Hz, 4H), 2.19 – 2.12 (m, 2H), 0.96 (d, J = 6.6 Hz, 12H).13C NMR (100 MHz, Chloroform-d) δ 144.16, 142.04, 137.12, 133.36, 128.69, 127.66, 127.62, 127.33, 115.46, 103.93, 97.68, 61.56, 52.84, 26.74, 20.46.
,
Weighing compound A3-2 (5.65 g,25.3 mmol) potassium carbonate (13.99 g,101.2 mmol) in a 500 mL three-mouth bottle at the temperature of 22 ℃ under the condition of nitrogen, adding 63 mL of N, N-dimethylformamide, dissolving and stirring for 10 minutes, slowly adding iodoisobutane (18.6 g,101.2 mmol), transferring to a 130 ℃ oil bath pot, heating and reacting for 4 hours, cooling to the room temperature, sampling, quenching by water, extracting by an ethyl acetate extraction point plate until the raw materials are completely reacted, generating a target product, removing the oil bath pot, cooling to the room temperature, filtering by a sand core funnel to remove potassium carbonate, washing by ethyl acetate, collecting filtrate, extracting 3 times (50 mL of 3), collecting an organic phase, washing three times by saturated saline, collecting the organic phase, adding anhydrous sodium sulfate, drying, evaporating the organic phase under reduced pressure at 43 ℃ in a rotary manner to obtain a crude product, and separating by a column (ethyl acetate: n-hexane=1:30:1:5) to obtain compound A4-2 m white solid (2.97 g,42%).1H NMR (400 MHz, Chloroform-d) δ7.78 (s, 1H), 7.35 – 7.30 (m, 3H), 7.26 – 7.24 (m, 2H), 7.17-7.13 (m, 1H), 7.08 (d, J = 8.6 Hz, 1H), 6.07 (d, J = 7.1 Hz, 1H), 5.52 (s, 2H), 3.90 (s, 1H), 3.03 (d, J = 6.8 Hz, 2H), 1.95 (dp, J = 13.4, 6.7 Hz, 1H), 1.00 (d, J = 6.7 Hz, 6H).13C NMR (100 MHz, Chloroform-d) δ 150.14, 141.28, 135.99, 128.92, 128.32, 127.98, 127.74, 120.02, 115.16, 106.11, 97.92, 57.36, 51.72, 27.99, 20.64. to obtain compound A4-2 as red solid (1.23 g,14.5%).1H NMR (400 MHz, Chloroform-d) δ7.86 (s, 1H), 7.37 – 7.27 (m, 5H), 7.14 – 7.13 (m, 2H), 6.23 – 6.18 (m, 1H), 5.55 (s, 2H), 3.16 (d, J = 7.2 Hz, 4H), 2.04 – 1.97 (m, 2H), 0.85 (d, J = 6.7 Hz, 12H).13C NMR (100 MHz, Chloroform-d) δ 151.22, 143.58, 135.93, 128.93, 128.32, 128.03, 127.10, 122.83, 116.34, 106.99, 104.51, 61.24, 57.31, 26.70, 20.56.
Example 4
Transferring the compound A4-1 (4.24 g,15.18 mmol) into a 250 mL three-port reaction bottle under the condition of 18 ℃ and room temperature under the protection of nitrogen, stirring and dissolving, dropwise adding lithium bis (trimethylsilyl) amide (45.5 ml,1 mL/L) at 18 ℃, stirring for 1 hour, slowly adding iodized isobutane (3.52 mL,30.4 mmol), stirring for 1 hour, taking out a sampling point plate to show that the raw materials are not reacted completely (the extension time does not change, generating a target product, stopping the reaction, adding water for quenching, extracting 3 times with water and ethyl acetate (50 mL x 3), merging the organic phases, washing with saturated salt once, adding anhydrous sodium sulfate for drying, and carrying out reduced pressure rotary evaporation on the organic phases at 43 ℃ to obtain a crude product, and separating by a column (ethyl acetate: n-hexane=1:20-1:5). The starting beige solid compound A4-1 was recovered to give the liquid compound A5-1 (2.14 g, 42%) as a yellow oil.
Transferring compound A4-2 (2.97 g,10.6 mmol) into a 250 mL three-port reaction bottle with tetrahydrofuran (32 mL) under the protection of nitrogen at the temperature of 18 ℃ and stirring for dissolution, dropwise adding lithium bis (trimethylsilyl) amide (21.2 mL,1 mOL/L) at the temperature of 18 ℃ to find that yellow liquid becomes turbid gradually, slowly adding isobutene iodide (3.7 mL,31.8 mmol) and stirring for 1 hour (the yellow turbid system becomes brown clear liquid), sampling a sampling point plate shows that the raw material is not reacted completely (the product is unchanged, the target product is generated, stopping the reaction, adding water for quenching, extracting 3 times with water and ethyl acetate (50 x 3), combining the organic phases, washing one time with saturated salt, adding anhydrous sodium sulfate for drying, and carrying out reduced pressure evaporation on the organic phases at the temperature of 43 ℃ to obtain a crude product, and separating the crude product by a column (ethyl acetate: normal hexane=1:30:1:5). The beige solid compound A4-2 was recovered to give the compound A5-2 as a yellow oil (1.89 g, 53%).
Example 5
Transferring potassium tert-butoxide (8.43 g,75 mmol) to a 500 mL round bottom flask at 17 ℃ under room temperature, adding dimethyl sulfoxide (15.9 mL) under oxygen protection, adding 59. 59 mL tetrahydrofuran dissolved compound A5-1 (2.52 g,7.5 mmol), stirring for 12 hours, sampling the plates to show no raw material and new product, stopping the reaction, adding saturated sodium chloride aqueous solution 250 mL, extracting with ethyl acetate (4 x 60 mL), merging the organic phases, washing the organic phases with saturated salt once, adding anhydrous sodium sulfate for drying, decompressing and steaming the organic phases under 45 ℃ to obtain a crude product, and separating the crude product by a column (ethyl acetate: n-hexane=1:10-1:5) to obtain a yellow solid compound a5(1.51 g,82%).1H NMR (400 MHz, Chloroform-d) δ 8.16 (d, J = 1.1 Hz, 1H), 7.28 – 7.22 (m, 1H), 6.85 (d, J = 8.1 Hz, 1H), 6.33 (d, J = 7.8 Hz, 1H), 3.37 (d, J = 7.3 Hz, 4H), 2.17 – 2.08 (m, 2H), 0.95 (d, J = 6.7 Hz, 12H).13C NMR (100 MHz, Chloroform-d) δ 144.06, 142.60, 134.73, 128.09, 114.74, 104.47, 98.23, 61.52, 26.73, 20.45.
Example 6
Transferring potassium tert-butoxide (10.44 g,93 mmol) to a 500 mL round bottom flask at 17 ℃ under room temperature, adding dimethyl sulfoxide (19.8 mL) under oxygen protection, adding 72 mL tetrahydrofuran dissolved compound A5-2 (3.12 g,9.3 mmol), stirring for 12 hours, sampling the plates to show no raw material and new product, stopping the reaction, adding saturated sodium chloride aqueous solution 250 mL, extracting with ethyl acetate (4 x 60 mL), merging the organic phases, washing the organic phases with saturated salt once, adding anhydrous sodium sulfate for drying, decompressing and steaming the organic phases at 45 ℃ to obtain a crude product, and separating the crude product by a column (ethyl acetate: n-hexane=1:10-1:5) to obtain a yellow solid compound a5(1.78 g,78%).1H NMR (400 MHz, Chloroform-d) δ8.16 (s, 1H), 7.29 – 7.22 (m, 1H), 6.85 (d, J = 8.1 Hz,1H), 6.34 (d, J = 7.8 Hz, 1H), 3.38 (d, J = 7.2 Hz, 4H), 2.17 – 2.10 (m, 2H), 0.95 (d, J = 6.6 Hz, 12H).13C NMR (100 MHz, Chloroform-d) δ 144.06, 142.61, 134.72, 128.09, 114.74, 104.45, 98.23, 61.52, 26.73, 20.45.
The foregoing description is only illustrative of the present invention and is not intended to limit the scope of the invention, and all equivalent structures or equivalent processes or direct or indirect application in other related arts are included in the scope of the present invention.

Claims (12)

Translated fromChinese
1.具有以下通式(I)的化合物,其结构式为:1. A compound having the following general formula (I), the structural formula of which is: ,其中:in:A为4~7元不饱和的含有1~2个杂原子N,O的杂环;A is a 4-7 membered unsaturated heterocyclic ring containing 1-2 heteroatoms N and O;n为1~3的整数;n is an integer from 1 to 3;R1为取代基,包括H或烷基、烷氧基,其中,烷基可以是甲基、乙基、丙基、异丙基;R1 is a substituent, including H or alkyl, alkoxy, wherein the alkyl can be methyl, ethyl, propyl, isopropyl;Q分别独立为HR3或R2,R3和R2可以是一个或多个-CH2-C1-6烷基、-CH2-C1-6烷氧基、卤代-CH2-C1-6烷基。Q is independently HR3 or R2 , and R3 and R2 may be one or more -CH2 -C1-6 alkyl, -CH2 -C1-6 alkoxy, or halogenated -CH2 -C1-6 alkyl.2.根据权利要求1所述的式(I)化合物,其特征在于,2. The compound of formula (I) according to claim 1, characterized in that当Q独立为HR3,R3表示权利要求1中定义的一个或多个-CH2-C1-6烷基时,式(l)的化合物具有下列式(Ia)的结构:When Q is independently HR3 and R3 represents one or more -CH2 -C1-6 alkyl groups as defined in claim 1, the compound of formula (1) has the structure of the following formula (Ia): ,当Q独立为R2, R2表示权利要求1中定义的一个或多个-CH2-C1-6烷基时,式(l)的化合物具有下列式(Ib)的结构:When Q is independently R2 , and R2 represents one or more —CH2 —C1-6 alkyl groups as defined in claim 1 , the compound of formula (1) has the structure of the following formula (Ib): ,其中,A为5元不饱和的含有1~2个杂原子N,O的杂环;Wherein, A is a 5-membered unsaturated heterocyclic ring containing 1 to 2 heteroatoms N and O;n,p为1~2整数;n, p are integers from 1 to 2;R1为H或烷基。R1 is H or alkyl.3.根据权利要求2所述的式(I)化合物,其特征在于,其中,A选自下述基团:3. The compound of formula (I) according to claim 2, wherein A is selected from the following groups: , , , , .4.根据权利要求1~3中任一项所述的式(I)化合物,其特征在于,所述式(I)化合物的结构式为:4. The compound of formula (I) according to any one of claims 1 to 3, characterized in that the structural formula of the compound of formula (I) is: , , .5.一种式(I)化合物的制备方法,其特征在于,由式(III)化合物经还原剂还原,制备得到式(II)化合物,再由式(II)化合物在碱性条件下经连续取代反应制备得到式(I)化合物,反应方程式如下:5. A method for preparing a compound of formula (I), characterized in that the compound of formula (III) is reduced with a reducing agent to prepare a compound of formula (II), and then the compound of formula (II) is subjected to a continuous substitution reaction under alkaline conditions to prepare a compound of formula (I), and the reaction equation is as follows:,其中,A,n,R1,Q的定义与上述定义中相同。 , wherein A, n, R1 , and Q are defined the same as above.6.根据权利要求5所述的制备方法,其特征在于,由式(II-2)化合物在碱性条件下经连续取代反应制备得到式(Ib-2)化合物,反应方程式如下:6. The preparation method according to claim 5, characterized in that the compound of formula (Ib-2) is prepared by continuous substitution reaction of the compound of formula (II-2) under alkaline conditions, and the reaction equation is as follows:,其中,A为5元不饱和的含有2个杂原子N的杂环,n,p为1,R1为H。 , wherein A is a 5-membered unsaturated heterocyclic ring containing 2 heteroatoms N, n, p are 1, and R1 is H.7.根据权利要求5所述的制备方法,其特征在于,所述还原剂为铁粉;所述酸性条件为氯化铵、盐酸、硫酸;所述铁粉用量为1.0~2.5 eq;所述溶剂选自水、四氢呋喃、甲醇、乙醇、丙醇、异丙醇、丁醇、六甲基磷酰胺、二甲基醚、二乙基醚、二异丙基醚、乙酸乙酯、二甲氧基乙烷中的多种。7. The preparation method according to claim 5, characterized in that the reducing agent is iron powder; the acidic conditions are ammonium chloride, hydrochloric acid, and sulfuric acid; the amount of iron powder is 1.0~2.5 eq; and the solvent is selected from a plurality of water, tetrahydrofuran, methanol, ethanol, propanol, isopropanol, butanol, hexamethylphosphoramide, dimethyl ether, diethyl ether, diisopropyl ether, ethyl acetate, and dimethoxyethane.8.根据权利要求5所述的制备方法,其特征在于,所述碱为二(三甲基硅基)胺基锂、二(三甲基硅基)胺基钠、二(三甲基硅基)胺基钾、氨基钠、氢化钠中的任何一种,优选地为二(三甲基硅基)胺基锂;所述碱可以在1.0~1.3 eq;所述溶剂选自四氢呋喃、甲苯、二甲基醚、二乙基醚、二异丙基醚中的一种。8. The preparation method according to claim 5, characterized in that the base is any one of lithium bis(trimethylsilyl)amide, sodium bis(trimethylsilyl)amide, potassium bis(trimethylsilyl)amide, sodium amide, and sodium hydride, preferably lithium bis(trimethylsilyl)amide; the base can be 1.0-1.3 eq; and the solvent is selected from one of tetrahydrofuran, toluene, dimethyl ether, diethyl ether, and diisopropyl ether.9.根据权利要求6所述的制备方法,其特征在于,所述碱为碳酸钠、碳酸氢钠、碳酸钾、一碱磷酸钾、二碱磷酸钾、三碱磷酸钾、一碱磷酸钠、二碱磷酸钠、三碱磷酸钠中的一种;所述碱在1.0~1.3 eq;所述溶剂选自N,N-二甲基甲酰胺、四氢呋喃、二氯甲烷、N-甲基吡咯烷酮、六甲基磷酰胺、二甲基醚、二甲基亚砜中的一种或几种。9. The preparation method according to claim 6, characterized in that the base is one of sodium carbonate, sodium bicarbonate, potassium carbonate, monobasic potassium phosphate, dibasic potassium phosphate, tribasic potassium phosphate, monobasic sodium phosphate, dibasic sodium phosphate, and tribasic sodium phosphate; the base is 1.0~1.3 eq; the solvent is selected from one or more of N,N-dimethylformamide, tetrahydrofuran, dichloromethane, N-methylpyrrolidone, hexamethylphosphoramide, dimethyl ether, and dimethyl sulfoxide.10.根据权利要求5或6所述的制备方法,其特征在于,所述式(III)化合物通过如下方式制备:10. The preparation method according to claim 5 or 6, characterized in that the compound of formula (III) is prepared by the following method: .11.根据权利要求5或6所述的制备方法,其特征在于,进一步制备化合物N,N-二异丁基-1H-吲唑-4-胺(a5),包括如下方式:11. The preparation method according to claim 5 or 6, characterized in that the compound N,N-diisobutyl-1H-indazol-4-amine (a5) is further prepared by the following method:化合物(A5-1)或(A5-2)与溴苄进行脱保护基反应得到化合物N,N-二异丁基-1H-吲唑-4-胺(a5):Compound (A5-1) or (A5-2) is subjected to a deprotection reaction with benzyl bromide to obtain compound N,N-diisobutyl-1H-indazol-4-amine (a5): .12.根据权利要求5或6所述的制备方法,其特征在于,包括如下步骤:12. The preparation method according to claim 5 or 6, characterized in that it comprises the following steps:或者如下步骤, Or the following steps, .
CN202510502259.4A2025-04-222025-04-22 An intermediate of N,N-diisobutyl-1H-indazole-4-amine and preparation method thereofPendingCN120025281A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN202510502259.4ACN120025281A (en)2025-04-222025-04-22 An intermediate of N,N-diisobutyl-1H-indazole-4-amine and preparation method thereof

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN202510502259.4ACN120025281A (en)2025-04-222025-04-22 An intermediate of N,N-diisobutyl-1H-indazole-4-amine and preparation method thereof

Publications (1)

Publication NumberPublication Date
CN120025281Atrue CN120025281A (en)2025-05-23

Family

ID=95737787

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN202510502259.4APendingCN120025281A (en)2025-04-222025-04-22 An intermediate of N,N-diisobutyl-1H-indazole-4-amine and preparation method thereof

Country Status (1)

CountryLink
CN (1)CN120025281A (en)

Citations (10)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN1079961A (en)*1992-03-091993-12-29泽尼卡有限公司New arylindazoles and they are as the purposes of weedicide
US20040116388A1 (en)*1999-10-072004-06-17Amgen Inc.Kinase inhibitors
CN1863779A (en)*2003-10-152006-11-15宇部兴产株式会社Novel indazole derivative
WO2007028445A1 (en)*2005-07-152007-03-15Glaxo Group Limited6-indolyl-4-yl-amino-5-halogeno-2-pyrimidinyl-amino derivatives
CN108603038A (en)*2016-02-022018-09-28Agc株式会社Near infrared absorbing coloring matter, optical filter and photographic device
CN115315421A (en)*2019-12-132022-11-08日本新药株式会社Compounds and compositions as PDGF receptor kinase inhibitors
US20230312466A1 (en)*2020-09-012023-10-05Nrg Therapeutics LtdNovel compounds
CN117229216A (en)*2022-06-062023-12-15重庆博腾制药科技股份有限公司Preparation method of entecavir intermediate
US20250059172A1 (en)*2021-12-282025-02-20Nippon Shinyaku Co., Ltd.Indazole compound and pharmaceutical
CN119735550A (en)*2024-12-192025-04-01三明学院 A method for synthesizing fluorine-containing indazole derivatives

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN1079961A (en)*1992-03-091993-12-29泽尼卡有限公司New arylindazoles and they are as the purposes of weedicide
US20040116388A1 (en)*1999-10-072004-06-17Amgen Inc.Kinase inhibitors
CN1863779A (en)*2003-10-152006-11-15宇部兴产株式会社Novel indazole derivative
WO2007028445A1 (en)*2005-07-152007-03-15Glaxo Group Limited6-indolyl-4-yl-amino-5-halogeno-2-pyrimidinyl-amino derivatives
CN108603038A (en)*2016-02-022018-09-28Agc株式会社Near infrared absorbing coloring matter, optical filter and photographic device
CN115315421A (en)*2019-12-132022-11-08日本新药株式会社Compounds and compositions as PDGF receptor kinase inhibitors
US20230312466A1 (en)*2020-09-012023-10-05Nrg Therapeutics LtdNovel compounds
US20250059172A1 (en)*2021-12-282025-02-20Nippon Shinyaku Co., Ltd.Indazole compound and pharmaceutical
CN117229216A (en)*2022-06-062023-12-15重庆博腾制药科技股份有限公司Preparation method of entecavir intermediate
CN119735550A (en)*2024-12-192025-04-01三明学院 A method for synthesizing fluorine-containing indazole derivatives

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NAJAT ABBASSI 等: "ALKYLATION AND REDUCTION OF N-ALKYL-4-NITROINDAZOLES WITH ANHYDROUS SnCl2 IN ETHANOL: SYNTHESIS OF NOVEL 7-ETHOXY-N-ALKYLINDAZOLE DERIVATIVES", 《HETEROCYCLES》, vol. 83, no. 4, 3 March 2011 (2011-03-03), pages 892 - 893*
朱建光 等: "《有机化学》", vol. 1, 31 March 2002, 治金工业出版社, pages: 113*

Similar Documents

PublicationPublication DateTitle
CN111116676B (en) A kind of N-heterocyclic carbene palladium complex with ptycene structure and application thereof
JP4691779B2 (en) Pyridine derivatives and their complexes
CN113234097A (en)tBu-azaBODIPY photo-thermal dye and preparation method thereof
CN110218207B (en)Coumarin hybrid pyridone compound with iron chelation and monoamine oxidase B inhibition activity and preparation and application thereof
CN111825655A (en) A high-sensitivity fluorescent probe for detecting Hg2+ and its preparation method and application
CN115894498A (en) A kind of potential antiviral drug intermediate BL and its synthetic method
CN106083539B (en)A kind of synthetic method of list fluorine methoxyl group or the deuterated methoxy base class compound of single fluorine
CN120025281A (en) An intermediate of N,N-diisobutyl-1H-indazole-4-amine and preparation method thereof
CN115260205B (en) Bispyrene-doped extended porphyrin, its double palladium metal complex, its preparation method and application
CN111253272B (en)Method for preparing benzamide compound
CN110746444B (en)Crown ether compound, preparation method thereof and application thereof in ion recognition
CN108047243A (en)A kind of five butterfly alkene tetracarboxylic acid dianhydride compounds of 2,3,6,7- and its synthetic method
CN114853690A (en)Preparation method of butonol
CN104447548A (en)Process for synthesizing substituted isoquinolines
CN113801170A (en) A kind of bromine atom modified blue light absorption enhanced iridium (III) complex and preparation method thereof
CN105753873A (en)Preparation method of octahydroxy Schiff base metal phthalocyanine
CN107382898B (en)Energetic material based on ANPZ energetic parent structure and synthetic method thereof
CN110172076A (en)One kind quinoline containing exocyclic double bond and preparation method thereof
CN116144034B (en) Metallic triangular supramolecules with near-infrared fluorescence, preparation methods and applications
CN116836107B (en)Carbazol eight-membered ring large conjugated structure OLED material and preparation method thereof
CN119285449B (en)Condensed ring base macrocyclic arene and its synthesis method
CN101328318B (en)Water-soluble linear polymethine 3H-indole cyanine dyes ultrasonic synthesis method
CN115124490B (en)Rigid polydentate tetracarboxylic acid organic ligand with thiadiazole functional group for preparing metal organic framework and preparation method thereof
CN110407718B (en) Benzimide Derivatives Using Triphenylamine as Donor and Their Preparation and Application
CN116041356A (en)Monophenol functionalized cucurbituril derivative and preparation method thereof

Legal Events

DateCodeTitleDescription
PB01Publication
PB01Publication
SE01Entry into force of request for substantive examination
SE01Entry into force of request for substantive examination

[8]ページ先頭

©2009-2025 Movatter.jp